Mami Iima1, Akira Yamamoto1, Tomohisa
Okada1, Mitsunori Kanagaki1, Denis Le Bihan2,3,
Seiko Kasahara1, Emiko Morimoto1, Satoshi Nakajima1,
Ryo Sakamoto1, Taha Mohamed Mehemed1, Kaori Togashi1
1Department of Diagnostic
Imaging & Nuclear Medicine, Kyoto University Graduate School of Medicine,
Kyoto, Japan; 2Human Brain Research Center, Kyoto University
Graduate School of Medicine, Kyoto, Japan; 3Neurospin, CEA-Saclay
Center, Gif-sur-Yvette, France
We implemented GRAPPA-accelerated RS-EPI DTI and SS-EPI DTI at 3T MR scanner with 32-channel head coil, and evaluated the feasibility of clinical application by comparing these two acquisition methods. RS-EPI has much reduced susceptibility compared with SS-EPI and can be a potential to be an alternative to SS-EPI DTI for evaluating CVJ lesion, such as demyelinating disease, neurodegenerative disease, brain tumors, skull base tumor, and inflammation.